Sun Nelson, CFO of Aardvark Therapeutics ($AARD), bought shares on the open market twice in the last year, totaling about $92,000. His most recent purchase was on December 11, 2025. These buys rank 2472nd among 4983 insiders averaging $1.5 million per person and 3.3 transactions. Sun Nelson reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | A | Stock option (right to buy) | 70549 | $0.00 | 70,549.0000 | 21,773,272 | 50.00% | 0.32% |
| Dec. 11, 2025 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | P | Common Stock | 3000 | $14.40 | 108,484.0000 | 21,773,272 | 2.84% | 0.01% |
| Sept. 9, 2025 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | P | Common Stock | 6000 | $8.07 | 105,484.0000 | 0 | 6.03% | 0.00% |
| June 11, 2025 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | A | Stock Option (right to buy) | 209826 | $0.00 | 209,826.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | C | Series C Convertible Preferred Stock | 59332 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | C | Common Stock | 7001 | $0.00 | 89,484.0000 | 0 | 8.49% | 0.00% |
| Feb. 14, 2025 | Aardvark Therapeutics, Inc. | $AARD | Sun Nelson | Chief Financial Officer | P | Common Stock | 10000 | $16.00 | 99,484.0000 | 0 | 11.18% | 0.00% |